Surface Oncology
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Surface Oncology's past years’ income statements indicate that its last revenue has increased compared to the previous period by 1016% to $30,000,000. The net income raised on -$65,303,000 and profit margin reached -218%. Total operating expenses were $91,869,000.
Profit Margin
| 2016 | 6.63M | -17.45M | -263.16% |
|---|---|---|---|
| 2017 | 12.82M | -45.37M | -353.79% |
| 2018 | 59.41M | -6.59M | -11.1% |
| 2019 | 15.36M | -53.00M | -345.08% |
| 2020 | 126.16M | 59.33M | 47.03% |
| 2021 | 2.68M | -79.46M | -2957.28% |
| 2022 | 30M | -65.30M | -217.68% |
SURF Income Statement (2016 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|
Revenue | |||||||
Revenue | 30M | 2.68M | 126.16M | 15.36M | 59.41M | 12.82M | 6.63M |
Cost of revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Gross profit | 30M | 2.68M | 126.16M | 15.36M | 59.41M | 12.82M | 6.63M |
Operating exp. | |||||||
Research and development | 67.00M | 53.57M | 41.01M | 52.11M | 52.49M | 47.78M | 20.49M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 91.86M | 78.7M | 64.57M | 72.72M | 68.56M | 58.81M | 24.63M |
Operating income | -61.86M | -76.01M | 61.58M | -57.36M | -9.15M | -45.99M | -18.00M |
Other income (expenses), net | -1.71M | -2.47M | -2.24M | 2.57M | 2.55M | 613K | 551K |
Income before tax | -63.58M | -78.48M | 59.33M | -54.78M | -6.59M | -45.37M | -17.45M |
Income tax expense | 1.71M | 977K | 579K | -1.78M | 2.55M | 0 | 0 |
Net income | -65.30M | -79.46M | 59.33M | -53.00M | -6.59M | -45.37M | -17.45M |
Earnings per share | |||||||
Basic EPS | -1.17 | -1.8 | 1.67 | -1.9 | -0.33 | -2.35 | -0.9 |
Diluted EPS | -1.17 | -1.8 | 1.57 | -1.9 | -0.33 | -2.35 | -0.9 |
| Data source | Data source | Data source | Data source | Data source |